Contribution of FDOPA PET to radiotherapy planning for advanced glioma

17th International Conference on the Use of Computers in Radiation Therapy

物理学;计算机科学

Dowson, Nicholas^1 ; Fay, Michael^2,3,4 ; Thomas, Paul^2,3 ; Jeffree, Rosalind^2,3 ; McDowall, Robert^2 ; Winter, Craig^2 ; Coulthard, Alan^2,3 ; Smith, Jye^2,3 ; Gal, Yaniv^3 ; Bourgeat, Pierrick^1 ; Salvado, Olivier^1,3 ; Crozier, Stuart^3 ; Rose, Stephen^1,3

Australian E-Health Research Centre, CSIRO, Australia^1

Departments of Nuclear Medicine, Radiology, Radiation Oncology, and Neurosurgery, Royal Brisbane and Women's Hospital, Australia^2

University of Queensland, St Lucia, Australia^3

Eberhard Karls Universitat Tubingen, Germany^4

关键词: Conformal radiotherapy;    Contrast-enhanced;    MRI scan;    PET data;    Radical treatment;    Radiotherapy planning;    Sensitivity and specificity;    Target volumes;   

Others  :  https://iopscience.iop.org/article/10.1088/1742-6596/489/1/012028/pdf
DOI  :  10.1088/1742-6596/489/1/012028

学科分类：计算机科学（综合）

来源: IOP

【 摘 要 】

Despite radical treatment with surgery, radiotherapy and chemotherapy, advanced gliomas recur within months. Geographic misses in radiotherapy planning may play a role in this seemingly ineluctable recurrence. Planning is typically performed on post-contrast MRIs, which are known to underreport tumour volume relative to FDOPA PET scans. FDOPA PET fused with contrast enhanced MRI has demonstrated greater sensitivity and specificity than MRI alone. One sign of potential misses would be differences between gross target volumes (GTVs) defined using MRI alone and when fused with PET. This work examined whether such a discrepancy may occur. Materials and Methods: For six patients, a 75 minute PET scan using 3,4-dihydroxy-6-18F-fluoro-L-phynel-alanine (18F-FDOPA) was taken within 2 days of gadolinium enhanced MRI scans. In addition to standard radiotherapy planning by an experienced radiotherapy oncologist, a second gross target volume (GTV) was defined by an experienced nuclear medicine specialist for fused PET and MRI, while blinded to the radiotherapy plans. The volumes from standard radiotherapy planning were compared to the PET defined GTV. Results: The comparison indicated radiotherapy planning would change in several cases if FDOPA PET data was available. PET-defined contours were external to 95% prescribed dose for several patients. However, due to the radiotherapy margins, the discrepancies were relatively small in size and all received a dose of 50 Gray or more. Conclusions: Given the limited size of the discrepancies it is uncertain that geographic misses played a major role in patient outcome. Even so, the existence of discrepancies indicates that FDOPA PET could assist in better defining margins when planning radiotherapy for advanced glioma, which could be important for highly conformal radiotherapy plans.